Investigation and assessment of cardiovascular safety of anticancer medicinal products

Keywords: Cardiovascular safety, oncology, anticancer medicinal products, anticancer drugs

Current version

Reflection paper on investigation and assessment of cardiovascular safety of anticancer medicinal products

Draft: consultation open Consultation dates: 22/01/2026 to 31/07/2026 Reference Number: EMA/8699/2026 Summary:

Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.

Document history

Concept paper on the need for a reflection paper on assessment of cardiovascular safety of oncology medicinal products

Draft: consultation closed Consultation dates: 01/08/2024 to 31/10/2024 Reference Number: EMA/CHMP/322756/2024 Summary:

Comments should be provided using this EUSurvey form. For any technical issues, please contact the EUSurvey Support.